PharmaEngine announces first patient dosed in PEP08 Phase I clinical trial for solid tumor cancers

PharmaEngine recognized as one of 2025 Taiwan Best-in-Class Companies by Taiwan Institute of Directors

PharmaEngine announces TFDA approval of PEP08 Phase 1 clinical trial for solid tumor cancers